Literature DB >> 20841385

Method of detection and breast cancer survival disparities in Hispanic women.

Deirdre A Hill1, Andrea Nibbe, Melanie E Royce, Anne Marie Wallace, Huining Kang, Charles L Wiggins, Robert D Rosenberg.   

Abstract

BACKGROUND: Hispanic women in New Mexico (NM) are more likely than non-Hispanic women to die of breast cancer-related causes. We determined whether survival differences between Hispanic and non-Hispanic women might be attributable to the method of detection, an independent breast cancer prognostic factor in previous studies.
METHODS: White women diagnosed with invasive breast cancer from 1995 through 2004 were identified from NM Surveillance Epidemiology End Results (SEER) files (n = 5,067) and matched to NM Mammography Project records. Method of cancer detection was categorized as "symptomatic" or "screen-detected." The proportion of Hispanic survival disparity accounted for by included variables was assessed using Cox models.
RESULTS: In the median follow-up of 87 months, 490 breast cancer deaths occurred. Symptomatic versus screen-detection was classifiable for 3,891 women (76.8%), and was independently related to breast cancer-specific survival [hazard ratio (HR), 1.6; 95% confidence interval (95% CI), 1.3-2.0]. Hispanic women had a 1.5-fold increased risk of breast cancer-related death, relative to non-Hispanic women (95% CI, 1.2-1.8). After adjustment for detection method, the Hispanic HR declined from 1.50 to 1.45 (10%), but after inclusion of other prognostic indicators the Hispanic HR equaled 1.23 (95% CI, 1.01-1.48).
CONCLUSIONS: Although the Hispanic HR declined 50% after adjustment, the decrease was largely due to adverse tumor prognostic characteristics. IMPACT: Reduction of disparate survival in Hispanic women may rely not only on increased detection of tumors when asymptomatic but on the development of greater understanding of biological factors that predispose to poor prognosis tumors. ©2010 AACR.

Entities:  

Mesh:

Year:  2010        PMID: 20841385      PMCID: PMC3402167          DOI: 10.1158/1055-9965.EPI-10-0164

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  20 in total

1.  Mediators of the association between mortality risk and socioeconomic status.

Authors:  Daniel J Brotman
Journal:  JAMA       Date:  2006-08-16       Impact factor: 56.272

2.  Breast Cancer Surveillance Consortium: a national mammography screening and outcomes database.

Authors:  R Ballard-Barbash; S H Taplin; B C Yankaskas; V L Ernster; R D Rosenberg; P A Carney; W E Barlow; B M Geller; K Kerlikowske; B K Edwards; C F Lynch; N Urban; C A Chrvala; C R Key; S P Poplack; J K Worden; L G Kessler
Journal:  AJR Am J Roentgenol       Date:  1997-10       Impact factor: 3.959

3.  Racial disparities in treatment and survival among women with early-stage breast cancer.

Authors:  Dawn Hershman; Russell McBride; Judith S Jacobson; Lois Lamerato; Kevin Roberts; Victor R Grann; Alfred I Neugut
Journal:  J Clin Oncol       Date:  2005-09-20       Impact factor: 44.544

4.  Ethnicity and breast cancer: factors influencing differences in incidence and outcome.

Authors:  Rowan T Chlebowski; Zhao Chen; Garnet L Anderson; Thomas Rohan; Aaron Aragaki; Dorothy Lane; Nancy C Dolan; Electra D Paskett; Anne McTiernan; F Alan Hubbell; Lucile L Adams-Campbell; Ross Prentice
Journal:  J Natl Cancer Inst       Date:  2005-03-16       Impact factor: 13.506

5.  Role of detection method in predicting breast cancer survival: analysis of randomized screening trials.

Authors:  Yu Shen; Ying Yang; Lurdes Y T Inoue; Mark F Munsell; Anthony B Miller; Donald A Berry
Journal:  J Natl Cancer Inst       Date:  2005-08-17       Impact factor: 13.506

6.  Method of primary tumor detection as a risk factor for local and distant recurrence after breast-conservation treatment for early-stage breast cancer.

Authors:  Julia Tchou; Joel Greshock; Meredith R Bergey; Seema S Sonnad; Michael Sargen; Susan Weinstein; Brian J Czerniecki; Marcia Boraas; Douglas L Fraker; Ernest Rosato; Kevin Fox; Barbara Weber; Lawrence J Solin
Journal:  Clin Breast Cancer       Date:  2008-04       Impact factor: 3.225

7.  Molecular subtypes of breast cancers detected in mammography screening and outside of screening.

Authors:  Harri Sihto; Johan Lundin; Tiina Lehtimäki; Maarit Sarlomo-Rikala; Ralf Bützow; Kaija Holli; Liisa Sailas; Vesa Kataja; Mikael Lundin; Taina Turpeenniemi-Hujanen; Jorma Isola; Päivi Heikkilä; Heikki Joensuu
Journal:  Clin Cancer Res       Date:  2008-07-01       Impact factor: 12.531

8.  Prognostic role of detection method and its relationship with tumor biomarkers in breast cancer: the university of Texas M.D. Anderson Cancer Center experience.

Authors:  Wenli Dong; Donald A Berry; Therese B Bevers; Shu-Wan Kau; Limin Hsu; Richard L Theriault; Yu Shen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-05       Impact factor: 4.254

9.  Hazard of recurrence and adjuvant treatment effects over time in lymph node-negative breast cancer.

Authors:  James J Dignam; Vanja Dukic; Stewart J Anderson; Eleftherios P Mamounas; D Lawrence Wickerham; Norman Wolmark
Journal:  Breast Cancer Res Treat       Date:  2008-10-02       Impact factor: 4.872

10.  Screen-detected vs symptomatic breast cancer: is improved survival due to stage migration alone?

Authors:  G C Wishart; D C Greenberg; P D Britton; P Chou; C H Brown; A D Purushotham; S W Duffy
Journal:  Br J Cancer       Date:  2008-05-27       Impact factor: 7.640

View more
  6 in total

Review 1.  Ethnic differences in breast cancer survival: status and determinants.

Authors:  Gertraud Maskarinec; Cherisse Sen; Karin Koga; Shannon M Conroy
Journal:  Womens Health (Lond)       Date:  2011-11

2.  Healthy lifestyle impact on breast cancer-specific and all-cause mortality.

Authors:  Adaline E Heitz; Richard N Baumgartner; Kathy B Baumgartner; Stephanie D Boone
Journal:  Breast Cancer Res Treat       Date:  2017-08-31       Impact factor: 4.872

3.  Active and passive cigarette smoking and mortality among Hispanic and non-Hispanic white women diagnosed with invasive breast cancer.

Authors:  Stephanie D Boone; Kathy B Baumgartner; Richard N Baumgartner; Avonne E Connor; Esther M John; Anna R Giuliano; Lisa M Hines; Shesh N Rai; Elizabeth C Riley; Christina M Pinkston; Roger K Wolff; Martha L Slattery
Journal:  Ann Epidemiol       Date:  2015-08-28       Impact factor: 3.797

4.  Current status of diagnosis and treatment of primary breast cancer in beijing, 2008.

Authors:  Xiao-Mei Yuan; Ning Wang; Tao Ouyang; Lei Yang; Ming-Yang Song; Ben-Yao Lin; Yun-Tao Xie; Jin-Feng Li; Kai-Feng Pan; Wei-Cheng You; Lian Zhang
Journal:  Chin J Cancer Res       Date:  2011-03       Impact factor: 5.087

5.  Breast cancer detection method, diagnostic interval and use of specialized diagnostic assessment units across Ontario, Canada.

Authors:  Li Jiang; Julie Gilbert; Hugh Langley; Rahim Moineddin; Patti A Groome
Journal:  Health Promot Chronic Dis Prev Can       Date:  2018-10       Impact factor: 3.240

6.  Global breast cancer: the lessons to bring home.

Authors:  Silvia C Formenti; Alan A Arslan; Susan M Love
Journal:  Int J Breast Cancer       Date:  2011-12-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.